Free regulatory intelligence — powered by Certivo
Regulation ChangeProposedProposed Regulation

Illinois SB1773 legislative status update: placed on House Calendar for 2nd Reading (Short Debate)

ISCA:SB 1773 - Xylazine Classification UpdateIllinois General AssemblyUS, Illinois
Announced

Feb 13, 2026

Description

The Illinois General Assembly status record for SB1773 shows the bill’s latest action as of 2/13/2026: ‘House: Placed on Calendar 2nd Reading – Short Debate.’ This is a legislative progress update indicating the proposal to amend the Illinois Controlled Substances Act (including xylazine scheduling and related provisions) remains pending and has not been shown as enacted on the ILGA status page. Compliance teams tracking potential controlled-substance handling, distribution, and professional-use exceptions in Illinois should monitor for subsequent House action and any enactment (Public Act) before treating requirements as in force.

Get compliance alerts for ISCA:SB 1773 - Xylazine Classification Update

Certivo tracks regulatory changes and automates compliance workflows for your products.

Start Free Trial